| 0 |
BEZOLD ABSCESS |
1 |
0.1429 |
| 1 |
PYLOROSPASM |
1 |
0.0455 |
| 2 |
ARTERIAL STENOSIS LIMB |
1 |
0.0196 |
| 3 |
ELEPHANTIASIS |
1 |
0.0149 |
| 4 |
ANAESTHETIC COMPLICATION CARDIAC |
1 |
0.0145 |
| 5 |
LUDWIG ANGINA |
1 |
0.0069 |
| 6 |
SOCIOECONOMIC PRECARITY |
1 |
0.0058 |
| 7 |
PROCEDURAL HYPERTENSION |
1 |
0.0053 |
| 8 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 9 |
GLOMERULONEPHRITIS ACUTE |
1 |
0.0049 |
| 10 |
PERIPHERAL NERVE OPERATION |
1 |
0.0046 |
| 11 |
VAGINAL MYCOSIS |
1 |
0.0043 |
| 12 |
INFESTATION |
1 |
0.0039 |
| 13 |
PANCREATIC INJURY |
1 |
0.0033 |
| 14 |
CAUSTIC INJURY |
1 |
0.0032 |
| 15 |
OESOPHAGEAL ACHALASIA |
2 |
0.0031 |
| 16 |
EAR OPERATION |
1 |
0.0027 |
| 17 |
MESOTHELIOMA MALIGNANT |
1 |
0.0027 |
| 18 |
VERTEBRAL OSTEOPHYTE |
1 |
0.0023 |
| 19 |
VULVOVAGINAL RASH |
1 |
0.0023 |
| 20 |
TUMOUR INVASION |
1 |
0.0021 |
| 21 |
BLEPHARAL PIGMENTATION |
1 |
0.0020 |
| 22 |
FAECAL VOLUME INCREASED |
1 |
0.0019 |
| 23 |
SCAPULA FRACTURE |
1 |
0.0019 |
| 24 |
RETROPERITONEAL LYMPHADENOPATHY |
1 |
0.0019 |
| 25 |
INSTILLATION SITE REACTION |
2 |
0.0018 |
| 26 |
PORTAL HYPERTENSIVE GASTROPATHY |
1 |
0.0018 |
| 27 |
ANTERIOR CHAMBER INFLAMMATION |
1 |
0.0017 |
| 28 |
SACRAL PAIN |
1 |
0.0016 |
| 29 |
MITRAL VALVE CALCIFICATION |
1 |
0.0016 |
| 30 |
HYPOTRICHOSIS |
1 |
0.0016 |
| 31 |
INJECTION SITE EXFOLIATION |
1 |
0.0015 |
| 32 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 33 |
TONGUE PARALYSIS |
1 |
0.0014 |
| 34 |
WITHDRAWAL BLEED |
1 |
0.0014 |
| 35 |
BACTERIAL DISEASE CARRIER |
1 |
0.0014 |
| 36 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 37 |
ENDOCARDITIS BACTERIAL |
1 |
0.0013 |
| 38 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 39 |
ADRENAL MASS |
1 |
0.0012 |
| 40 |
BILIARY DYSKINESIA |
2 |
0.0012 |
| 41 |
ABDOMINAL LYMPHADENOPATHY |
1 |
0.0012 |
| 42 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 43 |
OESOPHAGEAL OBSTRUCTION |
1 |
0.0012 |
| 44 |
FOLLICULAR LYMPHOMA |
1 |
0.0011 |
| 45 |
ABDOMINAL SEPSIS |
1 |
0.0011 |
| 46 |
MUSCLE CRAMP |
2 |
0.0011 |
| 47 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 48 |
LIPOATROPHY |
1 |
0.0011 |
| 49 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 50 |
SKIN OEDEMA |
1 |
0.0010 |
| 51 |
ONYCHALGIA |
1 |
0.0010 |
| 52 |
RENAL MASS |
2 |
0.0010 |
| 53 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 54 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 55 |
NAIL GROWTH ABNORMAL |
1 |
0.0009 |
| 56 |
DILATATION ATRIAL |
1 |
0.0009 |
| 57 |
INFREQUENT BOWEL MOVEMENTS |
2 |
0.0008 |
| 58 |
AUDITORY DISORDER |
1 |
0.0007 |
| 59 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 60 |
REBOUND ACID HYPERSECRETION |
2 |
0.0007 |
| 61 |
NEPHROGENIC ANAEMIA |
3 |
0.0006 |
| 62 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 63 |
TINEA PEDIS |
1 |
0.0006 |
| 64 |
OROPHARYNGEAL BLISTERING |
1 |
0.0006 |
| 65 |
EROSIVE OESOPHAGITIS |
1 |
0.0006 |
| 66 |
CAROTID ARTERY STENOSIS |
2 |
0.0006 |
| 67 |
DRUG SCREEN NEGATIVE |
1 |
0.0006 |
| 68 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 69 |
MOTION SICKNESS |
1 |
0.0005 |
| 70 |
VOCAL CORD DISORDER |
1 |
0.0005 |
| 71 |
PHYSICAL ASSAULT |
1 |
0.0005 |
| 72 |
BODY HEIGHT DECREASED |
5 |
0.0005 |
| 73 |
INFECTION SUSCEPTIBILITY INCREASED |
1 |
0.0005 |
| 74 |
DANDRUFF |
1 |
0.0005 |
| 75 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 76 |
FEAR OF DEATH |
1 |
0.0004 |
| 77 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 78 |
BREAKTHROUGH PAIN |
1 |
0.0004 |
| 79 |
PUSTULE |
1 |
0.0004 |
| 80 |
INSTILLATION SITE PAIN |
1 |
0.0004 |
| 81 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 82 |
VENTRICULAR HYPERTROPHY |
1 |
0.0004 |
| 83 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 84 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 85 |
TRICHORRHEXIS |
1 |
0.0004 |
| 86 |
JOINT LOCK |
1 |
0.0004 |
| 87 |
IMPAIRED DRIVING ABILITY |
4 |
0.0004 |
| 88 |
TUMOUR HAEMORRHAGE |
1 |
0.0004 |
| 89 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 90 |
DYSCHEZIA |
1 |
0.0003 |
| 91 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 92 |
MASTICATION DISORDER |
1 |
0.0003 |
| 93 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 94 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 95 |
CARDIAC FLUTTER |
2 |
0.0003 |
| 96 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 97 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 98 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 99 |
ULCER HAEMORRHAGE |
2 |
0.0003 |
| 100 |
HANGOVER |
1 |
0.0003 |
| 101 |
THERMAL BURN |
2 |
0.0003 |
| 102 |
SKIN WEEPING |
1 |
0.0003 |
| 103 |
AMYLASE INCREASED |
1 |
0.0003 |
| 104 |
FREEZING PHENOMENON |
1 |
0.0003 |
| 105 |
ORAL INFECTION |
1 |
0.0003 |
| 106 |
WOUND SECRETION |
1 |
0.0003 |
| 107 |
PROSTATOMEGALY |
1 |
0.0003 |
| 108 |
AZOTAEMIA |
1 |
0.0003 |
| 109 |
FOREIGN BODY |
1 |
0.0002 |
| 110 |
SPINAL COMPRESSION FRACTURE |
2 |
0.0002 |
| 111 |
SOCIAL PROBLEM |
1 |
0.0002 |
| 112 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 113 |
SLEEP TERROR |
1 |
0.0002 |
| 114 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 115 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 116 |
HORDEOLUM |
1 |
0.0002 |
| 117 |
CHAPPED LIPS |
1 |
0.0002 |
| 118 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 119 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 120 |
EXOSTOSIS |
2 |
0.0002 |
| 121 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 122 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 123 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 124 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0002 |
| 125 |
VULVOVAGINAL PAIN |
1 |
0.0002 |
| 126 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 127 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 128 |
VEIN DISORDER |
1 |
0.0002 |
| 129 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 130 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 131 |
SKIN NECROSIS |
1 |
0.0002 |
| 132 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 133 |
OVERWEIGHT |
1 |
0.0002 |
| 134 |
PRODUCT SIZE ISSUE |
1 |
0.0002 |
| 135 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 136 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 137 |
ASTHENOPIA |
1 |
0.0002 |
| 138 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 139 |
NECROSIS |
1 |
0.0002 |
| 140 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 141 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 142 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 143 |
HYPERVENTILATION |
1 |
0.0002 |
| 144 |
METABOLIC DISORDER |
1 |
0.0002 |
| 145 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 146 |
SINUS HEADACHE |
1 |
0.0002 |
| 147 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 148 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 149 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 150 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 151 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 152 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 153 |
TENDON DISORDER |
1 |
0.0002 |
| 154 |
POLYP |
1 |
0.0002 |
| 155 |
WALKING AID USER |
1 |
0.0002 |
| 156 |
SKIN MASS |
1 |
0.0001 |
| 157 |
CHOLECYSTITIS CHRONIC |
1 |
0.0001 |
| 158 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 159 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 160 |
INFARCTION |
1 |
0.0001 |
| 161 |
CHRONIC KIDNEY DISEASE |
11 |
0.0001 |
| 162 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 163 |
LARGE INTESTINE PERFORATION |
1 |
0.0001 |
| 164 |
HUNGER |
2 |
0.0001 |
| 165 |
EXTRASYSTOLES |
1 |
0.0001 |
| 166 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 167 |
INCORRECT DRUG ADMINISTRATION DURATION |
4 |
0.0001 |
| 168 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 169 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 170 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 171 |
POOR QUALITY SLEEP |
3 |
0.0001 |
| 172 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 173 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 174 |
HAIR DISORDER |
1 |
0.0001 |
| 175 |
EYE PRURITUS |
4 |
0.0001 |
| 176 |
PARANOIA |
2 |
0.0001 |
| 177 |
NAIL DISORDER |
1 |
0.0001 |
| 178 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 179 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 180 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 181 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 182 |
BLOOD CHOLESTEROL INCREASED |
5 |
0.0001 |
| 183 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 184 |
FLANK PAIN |
1 |
0.0001 |
| 185 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 186 |
PHOTOPHOBIA |
2 |
0.0001 |
| 187 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 188 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 189 |
EYE IRRITATION |
6 |
0.0001 |
| 190 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 191 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 192 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 193 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 194 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
| 195 |
SPINAL FRACTURE |
2 |
0.0001 |
| 196 |
THERAPY CESSATION |
5 |
0.0001 |
| 197 |
SKELETAL INJURY |
1 |
0.0001 |
| 198 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 199 |
EYE DISCHARGE |
1 |
0.0001 |
| 200 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 201 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 202 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 203 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 204 |
EXPIRED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 205 |
FOOT DEFORMITY |
1 |
0.0001 |
| 206 |
SNEEZING |
2 |
0.0001 |
| 207 |
EYE INFECTION |
1 |
0.0001 |
| 208 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 209 |
APPLICATION SITE PRURITUS |
2 |
0.0001 |
| 210 |
NEOPLASM |
1 |
0.0001 |
| 211 |
MADAROSIS |
1 |
0.0001 |
| 212 |
EYELID OEDEMA |
1 |
0.0001 |
| 213 |
VASCULITIS |
1 |
0.0001 |
| 214 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 215 |
BURSITIS |
1 |
0.0001 |
| 216 |
SCHIZOPHRENIA |
1 |
0.0001 |
| 217 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 218 |
CYST |
1 |
0.0001 |
| 219 |
ILEUS |
1 |
0.0001 |
| 220 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 221 |
PRODUCT USE ISSUE |
15 |
0.0001 |
| 222 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 223 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 224 |
HIATUS HERNIA |
1 |
0.0001 |
| 225 |
PHARMACEUTICAL PRODUCT COMPLAINT |
2 |
0.0001 |
| 226 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 227 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 228 |
RENAL FAILURE |
10 |
0.0001 |
| 229 |
GASTROOESOPHAGEAL REFLUX DISEASE |
6 |
0.0001 |
| 230 |
FEAR |
2 |
0.0001 |
| 231 |
JAUNDICE |
2 |
0.0001 |
| 232 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 233 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 234 |
DIALYSIS |
1 |
0.0001 |
| 235 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 236 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 237 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 238 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 239 |
SEPTIC SHOCK |
3 |
0.0001 |
| 240 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 241 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 242 |
THROAT IRRITATION |
3 |
0.0001 |
| 243 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 244 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 245 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
| 246 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 247 |
DEVICE FAILURE |
1 |
0.0001 |
| 248 |
ACUTE KIDNEY INJURY |
10 |
0.0001 |
| 249 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 250 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 251 |
DELUSION |
1 |
0.0001 |
| 252 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 253 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 254 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 255 |
IMPAIRED HEALING |
2 |
0.0001 |
| 256 |
MANIA |
1 |
0.0001 |
| 257 |
SKIN DISORDER |
2 |
0.0001 |
| 258 |
HEMIPARESIS |
1 |
0.0001 |
| 259 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 260 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 261 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 262 |
MUSCULOSKELETAL PAIN |
3 |
0.0001 |
| 263 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 264 |
HEART RATE DECREASED |
2 |
0.0001 |
| 265 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 266 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 267 |
GOUT |
1 |
0.0001 |
| 268 |
TOOTHACHE |
1 |
0.0001 |
| 269 |
DRUG EFFECT INCOMPLETE |
2 |
0.0001 |
| 270 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 271 |
DYSGEUSIA |
4 |
0.0001 |
| 272 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 273 |
FLATULENCE |
3 |
0.0001 |
| 274 |
COLITIS |
2 |
0.0001 |
| 275 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 276 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 277 |
INCREASED APPETITE |
1 |
0.0001 |
| 278 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 279 |
CHOLESTASIS |
1 |
0.0001 |
| 280 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 281 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 282 |
ERUCTATION |
1 |
0.0001 |
| 283 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 284 |
SINUS DISORDER |
1 |
0.0001 |
| 285 |
CONSTIPATION |
11 |
0.0001 |
| 286 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 287 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 288 |
FEEDING DISORDER |
1 |
0.0000 |
| 289 |
OSTEOPOROSIS |
2 |
0.0000 |
| 290 |
RIB FRACTURE |
1 |
0.0000 |
| 291 |
HYPERSENSITIVITY |
9 |
0.0000 |
| 292 |
PERITONITIS |
1 |
0.0000 |
| 293 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 294 |
DERMATITIS |
1 |
0.0000 |
| 295 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 296 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 297 |
JOINT INJURY |
1 |
0.0000 |
| 298 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 299 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 300 |
LIVER DISORDER |
2 |
0.0000 |
| 301 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 302 |
GLOSSODYNIA |
1 |
0.0000 |
| 303 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 304 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 305 |
ABDOMINAL PAIN UPPER |
9 |
0.0000 |
| 306 |
TINNITUS |
2 |
0.0000 |
| 307 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 308 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 309 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 310 |
INJURY |
3 |
0.0000 |
| 311 |
SLEEP DISORDER |
3 |
0.0000 |
| 312 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 313 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 314 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 315 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 316 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 317 |
ABASIA |
1 |
0.0000 |
| 318 |
WEIGHT INCREASED |
9 |
0.0000 |
| 319 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 320 |
CELLULITIS |
2 |
0.0000 |
| 321 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 322 |
DEPRESSION |
9 |
0.0000 |
| 323 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 324 |
GASTRIC CANCER |
1 |
0.0000 |
| 325 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 326 |
HAEMATEMESIS |
1 |
0.0000 |
| 327 |
ANXIETY |
11 |
0.0000 |
| 328 |
HAEMATOMA |
1 |
0.0000 |
| 329 |
NERVOUSNESS |
2 |
0.0000 |
| 330 |
GASTRITIS |
1 |
0.0000 |
| 331 |
EAR INFECTION |
1 |
0.0000 |
| 332 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 333 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 334 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 335 |
DRY MOUTH |
3 |
0.0000 |
| 336 |
LIMB INJURY |
1 |
0.0000 |
| 337 |
PALLOR |
1 |
0.0000 |
| 338 |
DRUG DOSE OMISSION |
6 |
0.0000 |
| 339 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 340 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 341 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 342 |
NECK PAIN |
2 |
0.0000 |
| 343 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 344 |
LETHARGY |
2 |
0.0000 |
| 345 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 346 |
DYSSTASIA |
1 |
0.0000 |
| 347 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 348 |
PALPITATIONS |
4 |
0.0000 |
| 349 |
ASCITES |
1 |
0.0000 |
| 350 |
CATARACT |
2 |
0.0000 |
| 351 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 352 |
IRRITABILITY |
2 |
0.0000 |
| 353 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 354 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 355 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 356 |
GYNAECOMASTIA |
1 |
0.0000 |
| 357 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 358 |
HEAD INJURY |
1 |
0.0000 |
| 359 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 360 |
HIP FRACTURE |
1 |
0.0000 |
| 361 |
PAIN IN EXTREMITY |
9 |
0.0000 |
| 362 |
DYSPEPSIA |
3 |
0.0000 |
| 363 |
EYE DISORDER |
1 |
0.0000 |
| 364 |
HEART RATE INCREASED |
3 |
0.0000 |
| 365 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 366 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 367 |
FALL |
10 |
0.0000 |
| 368 |
LIP SWELLING |
1 |
0.0000 |
| 369 |
FUNGAL INFECTION |
1 |
0.0000 |
| 370 |
GAIT INABILITY |
1 |
0.0000 |
| 371 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 372 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 373 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 374 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 375 |
GASTRIC DISORDER |
1 |
0.0000 |
| 376 |
VISION BLURRED |
4 |
0.0000 |
| 377 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 378 |
WEIGHT DECREASED |
8 |
0.0000 |
| 379 |
COUGH |
8 |
0.0000 |
| 380 |
BURNING SENSATION |
2 |
0.0000 |
| 381 |
HYPERKALAEMIA |
1 |
0.0000 |
| 382 |
HYPERTENSION |
6 |
0.0000 |
| 383 |
CRYING |
1 |
0.0000 |
| 384 |
RESTLESSNESS |
1 |
0.0000 |
| 385 |
MUSCLE SPASMS |
5 |
0.0000 |
| 386 |
DYSURIA |
1 |
0.0000 |
| 387 |
INJECTION SITE MASS |
1 |
0.0000 |
| 388 |
EYE SWELLING |
1 |
0.0000 |
| 389 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 390 |
EPISTAXIS |
2 |
0.0000 |
| 391 |
INSOMNIA |
7 |
0.0000 |
| 392 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 393 |
DIZZINESS |
13 |
0.0000 |
| 394 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 395 |
BACK PAIN |
6 |
0.0000 |
| 396 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 397 |
ARTHRITIS |
2 |
0.0000 |
| 398 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 399 |
DISORIENTATION |
1 |
0.0000 |
| 400 |
CARDIAC FAILURE |
2 |
0.0000 |
| 401 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 402 |
SOMNOLENCE |
5 |
0.0000 |
| 403 |
DYSPNOEA |
14 |
0.0000 |
| 404 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 405 |
BLINDNESS |
1 |
0.0000 |
| 406 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 407 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 408 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 409 |
ARTHRALGIA |
10 |
0.0000 |
| 410 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 411 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 412 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 413 |
URTICARIA |
4 |
0.0000 |
| 414 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 415 |
MENTAL DISORDER |
1 |
0.0000 |
| 416 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 417 |
TACHYCARDIA |
2 |
0.0000 |
| 418 |
DEHYDRATION |
3 |
0.0000 |
| 419 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 420 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 421 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 422 |
HYPOKALAEMIA |
1 |
0.0000 |
| 423 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 424 |
CARDIAC DISORDER |
2 |
0.0000 |
| 425 |
SWELLING |
2 |
0.0000 |
| 426 |
ARRHYTHMIA |
1 |
0.0000 |
| 427 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 428 |
DYSPHAGIA |
2 |
0.0000 |
| 429 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 430 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 431 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 432 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 433 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 434 |
CONTUSION |
2 |
0.0000 |
| 435 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 436 |
DRUG INEFFECTIVE |
27 |
0.0000 |
| 437 |
ALOPECIA |
4 |
0.0000 |
| 438 |
DRY EYE |
1 |
0.0000 |
| 439 |
SYNCOPE |
2 |
0.0000 |
| 440 |
FLUID RETENTION |
1 |
0.0000 |
| 441 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 442 |
ILLNESS |
2 |
0.0000 |
| 443 |
FATIGUE |
15 |
0.0000 |
| 444 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 445 |
HEADACHE |
12 |
0.0000 |
| 446 |
PANCREATITIS |
1 |
0.0000 |
| 447 |
OEDEMA |
1 |
0.0000 |
| 448 |
PRURITUS |
7 |
0.0000 |
| 449 |
TREMOR |
3 |
0.0000 |
| 450 |
ARTHROPATHY |
1 |
0.0000 |
| 451 |
PAIN |
11 |
0.0000 |
| 452 |
PANCYTOPENIA |
1 |
0.0000 |
| 453 |
BLISTER |
1 |
0.0000 |
| 454 |
HYPONATRAEMIA |
1 |
0.0000 |
| 455 |
EYE PAIN |
1 |
0.0000 |
| 456 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 457 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 458 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 459 |
DYSPHONIA |
1 |
0.0000 |
| 460 |
BONE PAIN |
1 |
0.0000 |
| 461 |
NASAL CONGESTION |
1 |
0.0000 |
| 462 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 463 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 464 |
DISCOMFORT |
1 |
0.0000 |
| 465 |
CHEST PAIN |
3 |
0.0000 |
| 466 |
ASTHENIA |
6 |
0.0000 |
| 467 |
PNEUMONIA |
5 |
0.0000 |
| 468 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 469 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 470 |
DRY SKIN |
2 |
0.0000 |
| 471 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 472 |
HYPOTENSION |
3 |
0.0000 |
| 473 |
VOMITING |
7 |
0.0000 |
| 474 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 475 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 476 |
OVERDOSE |
3 |
0.0000 |
| 477 |
NAUSEA |
11 |
0.0000 |
| 478 |
INFECTION |
2 |
0.0000 |
| 479 |
RASH |
6 |
0.0000 |
| 480 |
UNDERDOSE |
1 |
0.0000 |
| 481 |
MALAISE |
6 |
0.0000 |
| 482 |
BRONCHITIS |
1 |
0.0000 |
| 483 |
HYPOAESTHESIA |
2 |
0.0000 |
| 484 |
HALLUCINATION |
1 |
0.0000 |
| 485 |
HOT FLUSH |
1 |
0.0000 |
| 486 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 487 |
DIABETES MELLITUS |
1 |
0.0000 |
| 488 |
DECREASED APPETITE |
3 |
0.0000 |
| 489 |
PARAESTHESIA |
2 |
0.0000 |
| 490 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 491 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 492 |
FEELING ABNORMAL |
3 |
0.0000 |
| 493 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 494 |
MYALGIA |
2 |
0.0000 |
| 495 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 496 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 497 |
ADVERSE EVENT |
1 |
0.0000 |
| 498 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 499 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 500 |
MIGRAINE |
1 |
0.0000 |
| 501 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 502 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 503 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 504 |
ERYTHEMA |
2 |
0.0000 |
| 505 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 506 |
HAEMORRHAGE |
1 |
0.0000 |
| 507 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 508 |
DIARRHOEA |
6 |
0.0000 |
| 509 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 510 |
INFLUENZA |
1 |
0.0000 |
| 511 |
SEPSIS |
1 |
0.0000 |
| 512 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 513 |
SEIZURE |
1 |
0.0000 |
| 514 |
CHILLS |
1 |
0.0000 |
| 515 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 516 |
JOINT SWELLING |
1 |
0.0000 |
| 517 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 518 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 519 |
OFF LABEL USE |
7 |
0.0000 |
| 520 |
HYPERHIDROSIS |
1 |
0.0000 |
| 521 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 522 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 523 |
DRUG INTERACTION |
1 |
0.0000 |
| 524 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 525 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 526 |
PYREXIA |
2 |
0.0000 |
| 527 |
COVID-19 |
1 |
0.0000 |
| 528 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 529 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 530 |
ANAEMIA |
1 |
0.0000 |